Revenue
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | €60.1M | €56.2M | €34.0M | €19.6M | €12.6M | €9.8M |
| Research & development | — | — | — | — | €0 | — |
| Operating expenses | €50.9M | €37.7M | €28.7M | €19.1M | — | — |
| Operating income | −€18.9M | −€13.1M | −€14.1M | −€8.1M | −€4.2M | −€679,000 |
| Operating margin | −31.49% | −23.34% | −41.53% | −41.61% | −33.60% | −6.91% |
| EBITDA | −€8.2M | −€3.2M | −€6.7M | −€5.3M | — | — |
| EBITDA margin | −13.61% | −5.75% | −19.58% | −27.02% | — | — |
| Net income | −€29.5M | −€17.2M | −€15.4M | −€9.7M | −€7.7M | −€1.9M |
| Net profit margin | −49.17% | −30.67% | −45.37% | −49.49% | −61.11% | −19.46% |
| Basic EPSper basic share | -€1.35 | -€0.74 | -€0.78 | -€0.50 | -€0.41 | -€15.05 |
| Diluted EPSper diluted share | -€1.35 | -€0.74 | -€0.78 | -€0.50 | -€0.41 | -€15.05 |